{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Parkinson\u2019s disease", "chlorogenic acid", "dopaminergic neuron", "neuroinflammation", "oxidative stress", "substantia nigra"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30127737", "DateRevised": {"Year": "2023", "Month": "02", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "08", "Day": "06"}], "Language": ["eng"], "ELocationID": ["757", "10.3389/fphar.2018.00757"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "9", "PubDate": {"Year": "2018"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Effect of Chlorogenic Acid Supplementation in MPTP-Intoxicated Mouse.", "Pagination": {"StartPage": "757", "MedlinePgn": "757"}, "Abstract": {"AbstractText": ["Oxidative stress and neuroinflammation play a key role in dopaminergic (DA) neuronal degeneration, which results in the hindrance of normal ongoing biological processes in the case of Parkinson's disease. As shown in several studies, on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration, different behavioral parameters have suggested motor impairment and damage of antioxidant defence. Thus, some specific biological molecules found in medicinal plants can be used to inhibit the DA neuronal degeneration through their antioxidant and anti-inflammatory activities. With this objective, we studied chlorogenic acid (CGA), a naturally occurring polyphenolic compound, for its antioxidant and anti-inflammatory properties in MPTP-intoxicated mice. We observed significant reoccurrence of motor coordination and antioxidant defence on CGA supplementation, which has been in contrast with MPTP-injected mice. Moreover, in the case of CGA-treated mice, the enhanced expression of tyrosine hydroxylase (TH) within the nigrostriatal region has supported its beneficial effect. The activation of glial cells and oxidative stress levels were also estimated using inducible nitric oxide synthase (iNOS) and glial fibrillary acidic protein (GFAP) immunoreactivity within substantia nigra (SN) and striatum of MPTP-injected mice. Administration of CGA has prevented the neuroinflammation in SN by regulating the nuclear factor-\u03baB expression in the MPTP-induced group. The significant release of certain pro-inflammatory mediators such as tumor necrosis factor-\u03b1 and interleukin (IL)-1\u03b2 has also been inhibited by CGA with the enhanced expression of anti-inflammatory cytokine IL-10. Moreover, reduced GFAP staining within the nigrostriatal region has supported the fact that CGA has significantly helped in the attenuation of astrocyte activation. Hence, our study has shown that CGA supplementation shows its therapeutic ability by reducing the oxidative stress and neuroinflammation in MPTP-intoxicated mice."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India."}], "LastName": "Singh", "ForeName": "Saumitra S", "Initials": "SS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India."}], "LastName": "Rai", "ForeName": "Sachchida N", "Initials": "SN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India."}], "LastName": "Birla", "ForeName": "Hareram", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India."}], "LastName": "Zahra", "ForeName": "Walia", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biomedical Engineering, Indian Institute of Technology, Banaras Hindu University, Varanasi, India."}], "LastName": "Kumar", "ForeName": "Gaurav", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India."}], "LastName": "Gedda", "ForeName": "Mallikarjuna R", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India."}], "LastName": "Tiwari", "ForeName": "Neeraj", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biomedical Engineering, Indian Institute of Technology, Banaras Hindu University, Varanasi, India."}], "LastName": "Patnaik", "ForeName": "Ranjana", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India."}], "LastName": "Singh", "ForeName": "Rakesh K", "Initials": "RK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India."}], "LastName": "Singh", "ForeName": "Surya P", "Initials": "SP"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CommentsCorrectionsList": [{"RefSource": "Front Pharmacol. 2023 Feb 02;14:1145172. doi: 10.3389/fphar.2023.1145172", "PMID": "36814486"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Anderson G., Maes M. (2014). Neurodegeneration in Parkinson\u2019s disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins. Mol. Neurobiol. 49 771\u2013783. 10.1007/s12035-013-8554-z", "ArticleIdList": ["10.1007/s12035-013-8554-z", "24085563"]}, {"Citation": "Balasingam V., Yong V. W. (1996). Attenuation of astroglial reactivity by interleukin-10. J. Neurosci. 16 2945\u20132955.", "ArticleIdList": ["PMC6579053", "8622125"]}, {"Citation": "Bethea J. R., Nagashima H., Acosta M. C., Briceno C., Gomez F., Marcillo A. E., et al. (1999). Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 16 851\u2013863. 10.1089/neu.1999.16.851", "ArticleIdList": ["10.1089/neu.1999.16.851", "10547095"]}, {"Citation": "Block M. L., Zecca L., Hong J. S. (2007). Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8 57\u201369. 10.1038/nrn2038", "ArticleIdList": ["10.1038/nrn2038", "17180163"]}, {"Citation": "Blum D., Torch S., Lambeng N., Nissou M., Benabid A., Sadoul R., et al. (2001). Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson\u2019s disease. Prog. Neurobiol. 65 135\u2013172. 10.1016/S0301-0082(01)00003-X", "ArticleIdList": ["10.1016/S0301-0082(01)00003-X", "11403877"]}, {"Citation": "Boudjellab N., Chan-Tang H. S., Zhao X. (2000). Bovine interleukin-1 expression by cultured mammary epithelial cells (MAC-T) and its involvement in the release of MAC-T derived interleukin-8. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 127 191\u2013199. 10.1016/S1095-6433(00)00257-9", "ArticleIdList": ["10.1016/S1095-6433(00)00257-9", "11064286"]}, {"Citation": "Brewer K. L., Bethea J. R., Yezierski R. P. (1999). Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp. Neurol. 159 484\u2013493. 10.1006/exnr.1999.7173", "ArticleIdList": ["10.1006/exnr.1999.7173", "10506519"]}, {"Citation": "Celardo I., Martins L. M., Andhi S. F. (2014). Unravelling mitochondrial pathways to Parkinson\u2019s disease. Br. J. Pharmacol. 8 1943\u20131957. 10.1111/bph.12433", "ArticleIdList": ["10.1111/bph.12433", "PMC3976614", "24117181"]}, {"Citation": "Choi D. K., Pennathur S., Perier C., Tieu K., Teismann P., Wu D. C., et al. (2005). Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson\u2019s disease in mice. J. Neurosci. 25 6594\u20136600. 10.1523/JNEUROSCI.0970-05.2005", "ArticleIdList": ["10.1523/JNEUROSCI.0970-05.2005", "PMC6725426", "16014720"]}, {"Citation": "Chu Y. F., Brown P. H., Lyle B. J., Chen Y., Black R. M., Williams C. E., et al. (2009). Roasted coffees high in lipophilic antioxidants and chlorogenic acid lactones are more neuroprotective than green coffees. J. Agric. Food Chem. 57 9801\u20139808. 10.1021/jf902095z", "ArticleIdList": ["10.1021/jf902095z", "19772322"]}, {"Citation": "Clifford M. N. (1999). Chlorogenic acids and other cinnamates: nature, occurrence and dietary burden. J. Sci. Food Agric. 79 362\u2013372."}, {"Citation": "Cropley V., Croft R., Silber B., Neale C., Scholey A., Stough C., et al. (2012). Does coffee enriched with chlorogenic acids improve mood and cognition after acute administration in healthy elderly? A pilot study. Psychopharm 219 737\u2013749. 10.1007/s00213-011-2395-0", "ArticleIdList": ["10.1007/s00213-011-2395-0", "21773723"]}, {"Citation": "Cua D. J., Hutchins B., LaFace D. M., Stohlman S. A., Coffman R. L. (2001). Central nervous system expression ofIL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 166 602\u2013608. 10.4049/jimmunol.166.1.602", "ArticleIdList": ["10.4049/jimmunol.166.1.602", "11123343"]}, {"Citation": "Dauer W., Przedborski S. (2003). Parkinson\u2019s disease: mechanisms and models. Neuron 39 889\u2013909. 10.1016/S0896-6273(03)00568-3", "ArticleIdList": ["10.1016/S0896-6273(03)00568-3", "12971891"]}, {"Citation": "de Oliveira D. M., Barreto G., Galeano P., Romero J. I., Holubiec M. I., Badorrey M. S., et al. (2011). Paullinia cupana Mart. var. Sorbilis protects human dopaminergic neuroblastoma SH-SY5Y cell line against rotenone-induced cytotoxicity. Hum. Exp. Toxicol. 30 1382\u20131391. 10.1177/0960327110389837", "ArticleIdList": ["10.1177/0960327110389837", "21081703"]}, {"Citation": "di Meglio P., Ianaro A., Ghosh S. (2005). Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappa B activation. Arthritis Rheum. 52 951\u2013958. 10.1002/art.20960", "ArticleIdList": ["10.1002/art.20960", "15751079"]}, {"Citation": "Farah A., Donangelo C. M. (2006). Phenolic compounds in coffee. Braz. J. Plant Physiol. 18 23\u201336. 10.1590/S1677-04202006000100003", "ArticleIdList": ["10.1590/S1677-04202006000100003"]}, {"Citation": "Farah A., Monteiro M., Donangelo C. M., Lafay S. (2008). Chlorogenic acids from green coffee extract are highly bioavailable in humans. J. Nutr. 138 2309\u20132315. 10.3945/jn.108.095554", "ArticleIdList": ["10.3945/jn.108.095554", "19022950"]}, {"Citation": "Feng R., Lu Y., Bowman L. L., Qian Y., Castranova V., Ding M., et al. (2005). Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J. Biol. Chem. 280 27888\u201327895. 10.1074/jbc.M503347200", "ArticleIdList": ["10.1074/jbc.M503347200", "15944151"]}, {"Citation": "Figuera-Losada M., Rojas C., Slusher B. S. (2014). Inhibition of microglia activation as a phenotypic assay in early drug discovery. J. Biomol. Screen. 19 17\u201331. 10.1177/1087057113499406", "ArticleIdList": ["10.1177/1087057113499406", "PMC4111462", "23945875"]}, {"Citation": "Finsterwald C., Magistretti P. J., Lengacher S. (2015). Astrocytes: new targets for the treatment of neurodegenerative diseases. Curr. Pharm. Des. 21 3570\u20133581. 10.2174/1381612821666150710144502", "ArticleIdList": ["10.2174/1381612821666150710144502", "26166612"]}, {"Citation": "Frenkel D., Huang Z., Maron R., Koldzic D. N., Moskowitz M. A., Weiner H. L. (2005). Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J. Neurol. Sci. 233 125\u2013132. 10.1016/j.jns.2005.03.022", "ArticleIdList": ["10.1016/j.jns.2005.03.022", "15894335"]}, {"Citation": "Gandhi S., Wood N. W. (2005). Molecular pathogenesis of Parkinson\u2019s disease. Hum. Mol. Genet. 14 2749\u20132755. 10.1093/hmg/ddi308", "ArticleIdList": ["10.1093/hmg/ddi308", "16126732"]}, {"Citation": "Ghosh A., Roy A., Liu X., Kordower J. H., Mufson E. J., Hartley D. M., et al. (2007). Selective inhibition of NF-kB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease. Proc. Natl. Acad. Sci. U.S.A. 104 18754\u201318759.", "ArticleIdList": ["PMC2141849", "18000063"]}, {"Citation": "Gorbatyuk O. S., Li S., Sullivan L. F., Chen W., Kondrikova G., Manfredsson F. P., et al. (2008). The phosphorylation state of ser-129 in human \u03b1-synuclein determines neurodegeneration in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 105 763\u2013768. 10.1073/pnas.0711053105", "ArticleIdList": ["10.1073/pnas.0711053105", "PMC2206610", "18178617"]}, {"Citation": "Granger D. L., Taintor R. R., Boockvar K. S., Hibbs J. B. (1996). Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol. 268 142\u2013151.", "ArticleIdList": ["8782580"]}, {"Citation": "Han J., Miyamae Y., Shigemori H., Isoda H. (2010). Neuroprotective effect of 3,5-di-O-caffeoylquinic acid on SH-SY5Y cells and senescence-accelerated-prone mice 8 through the up-regulation of phosphoglycerate kinase 1. Neuroscience 169 1039\u20131045. 10.1016/j.neuroscience.2010.05.049", "ArticleIdList": ["10.1016/j.neuroscience.2010.05.049", "20570715"]}, {"Citation": "Herrera A. J., Casta\u00f1o A., Venero J. L., Cano J., Machado A. (2000). The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol. Dis. 7 429\u2013447.", "ArticleIdList": ["10964613"]}, {"Citation": "Hirsch E. C., Breidert T., Rousselet E., Hunot S., Hartmann A., Michel P. P. (2003). The role of glial reaction and inflammation in Parkinson\u2019s disease. Ann. N. Y. Acad. Sci. 991 214\u2013228. 10.1111/j.1749-6632.2003.tb07478.x", "ArticleIdList": ["10.1111/j.1749-6632.2003.tb07478.x", "12846989"]}, {"Citation": "Hirsch E. C., Hunot S. (2009). Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 8 382\u2013397. 10.1016/S1474-4422(09)70062-6", "ArticleIdList": ["10.1016/S1474-4422(09)70062-6", "19296921"]}, {"Citation": "Huang S. M., Chuang H. C., Wu C. H., Yen G. C. (2008). Cytoprotective effects of phenolic acids on methylglyoxal-induced apoptosis in neuro-2A cells. Mol. Nutr. Food Res. 52 940\u2013949. 10.1002/mnfr.200700360", "ArticleIdList": ["10.1002/mnfr.200700360", "18481334"]}, {"Citation": "Hwang S. J., Jun S. H., Park Y., Cha S. H., Yoon M., Cho S., et al. (2015). Green synthesis of gold nanoparticles using chlorogenic acid and their enhanced performance for inflammation. Nanomedicine 11 1677\u20131688. 10.1016/j.nano.2015.05.002", "ArticleIdList": ["10.1016/j.nano.2015.05.002", "26003298"]}, {"Citation": "Hwang S. J., Kim Y. W., Park Y., Lee H. J., Kim K. W. (2014). Anti-inflammatory effects of chlorogenic acid in lipopolysaccharide-stimulated RAW 264.7 cells. Inflamm. Res. 63 81\u201390. 10.1007/s00011-013-0674-4", "ArticleIdList": ["10.1007/s00011-013-0674-4", "24127072"]}, {"Citation": "Ito H., Sun X. L., Watanabe M., Okamoto M., Hatano T. (2008). Chlorogenic acid and its metabolite m-coumaric acid evoke neurite outgrowth in hippocampal neuronal cells. Biosci. Biotechnol. Biochem. 72 885\u2013888. 10.1271/bbb.70670", "ArticleIdList": ["10.1271/bbb.70670", "18323641"]}, {"Citation": "Jackson-Lewis V., Smeyne R. J. (2005). MPTP and SNpc DA neuronal vulner-ability: role of dopamine, superoxide and nitric oxide in neurotoxicity. Neurotoxicol. Res. 7 193\u2013202. 10.1007/BF03036449", "ArticleIdList": ["10.1007/BF03036449", "15897154"]}, {"Citation": "Jenner P., Olanow C. W. (1996). Oxidative stress and the pathogenesis of Parkinson\u2019s disease. Neurology 47(6 Suppl. 3) S161\u2013S170. 10.1212/WNL.47.6Suppl3.161S", "ArticleIdList": ["10.1212/WNL.47.6Suppl3.161S", "8959985"]}, {"Citation": "Jose L. M., Olivenza M., Moro M. A., Lizasoain I., Lorenzo P., Rodrigo J., et al. (2001). Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 24 420\u2013429. 10.1016/S0893-133X(00)00208-6", "ArticleIdList": ["10.1016/S0893-133X(00)00208-6", "11182537"]}, {"Citation": "Kanaan N. M., Kordower J. H., Collier T. J. (2010). Age-related changes in glial cells of dopamine midbrain subregions in rhesus monkeys. Neurobiol. Aging 31 937\u2013952. 10.1016/j.neurobiolaging.2008.07.006", "ArticleIdList": ["10.1016/j.neurobiolaging.2008.07.006", "PMC2872507", "18715678"]}, {"Citation": "Kitamura Y., Itano Y., Kubo T., Nomura Y. (1994). Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice. J. Neuroimmunol. 50 221\u2013224. 10.1016/0165-5728(94)90049-3", "ArticleIdList": ["10.1016/0165-5728(94)90049-3", "7509816"]}, {"Citation": "Kumar A., Ahmad I., Shukla S., Singh B. K., Patel D. K., Pandey H. P., et al. (2010). Effect of zinc and PQ co-exposure on neurodegeneration: modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats. Free Radic. Res. 44 1\u201316. 10.3109/10715762.2010.492832", "ArticleIdList": ["10.3109/10715762.2010.492832", "20553223"]}, {"Citation": "Kumar G., Paliwal P., Mukherjee S., Patnaik N., Krishnamurthy S., Patnaik R. (2018). Pharmacokinetics and brain penetration study of chlorogenic acid in rats. Xenobiotica 21 1\u20137. 10.1080/00498254.2018.1445882", "ArticleIdList": ["10.1080/00498254.2018.1445882", "29480050"]}, {"Citation": "Kurkowska-Jastrzebska I., Wronska A., Kohutnicka M., Czlonkowski A., Czlonkowska A. (1999). The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse. Exp. Neurol. 156 50\u201361. 10.1006/exnr.1998.6993", "ArticleIdList": ["10.1006/exnr.1998.6993", "10192776"]}, {"Citation": "Kwon S. H., Lee H. K., Kim J. A., Hong S. I., Kim H. C., Jo T. H., et al. (2010). Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. Eur. J. Pharmacol. 649 210\u2013217. 10.1016/j.ejphar.2010.09.001", "ArticleIdList": ["10.1016/j.ejphar.2010.09.001", "20854806"]}, {"Citation": "Lan X., Liu R., Sun L., Zhang T., Du G. (2011). Methyl salicylate 2-O-beta-D-lactoside, a novel salicylic acid analogue, acts as an anti-inflammatory agent on microglia and astrocytes. J. Neuroinflammation 8:98. 10.1186/1742-2094-8-98", "ArticleIdList": ["10.1186/1742-2094-8-98", "PMC3170234", "21831328"]}, {"Citation": "Langston J. W., Ballard P., Tetrud J. W., Irwin I. (1983). Chronic parkinsonism in humans due to a product of meperidine analog synthesis. Science 219 979\u2013980. 10.1126/science.6823561", "ArticleIdList": ["10.1126/science.6823561", "6823561"]}, {"Citation": "Langston J. W., Forno L. S., Tetrud J., Reeves A. G., Kaplan J. A., Karluk D. (1999). Evidence of active nerve cell degeneration in the Substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann. Neurol. 46 598\u2013605.", "ArticleIdList": ["10514096"]}, {"Citation": "Ledeboer A., Breve J. J., Wierinckx A., van der Jagt S., Bristow A. F., Leysen J. E., et al. (2002). Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells. Eur. J. Neurosci. 16 1175\u20131185. 10.1046/j.1460-9568.2002.02200.x", "ArticleIdList": ["10.1046/j.1460-9568.2002.02200.x", "12405978"]}, {"Citation": "Lee J. K., Tran T., Tansey M. (2009). Neuroinflammation in Parkinson\u2019s disease. J. Neuroimmune Pharmacol. 4 419\u2013429. 10.1016/S1353-8020(11)70065-7", "ArticleIdList": ["10.1016/S1353-8020(11)70065-7", "PMC3736976", "19821032"]}, {"Citation": "Lee J. M., Hwanga D. S., Kim H. G., Lee C. H., Oh M. S. (2012). Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions. J. Ethnopharmacol. 139 883\u2013888. 10.1016/j.jep.2011.12.015", "ArticleIdList": ["10.1016/j.jep.2011.12.015", "22178176"]}, {"Citation": "Lee J. W., Bannerman D. D., Paape M. J., Huang M. K., Zhao X. (2006). Characterization of cytokine expression in milk somatic cells during intramammary infections with Escherichia coli or Staphylococcus aureus by real-time PCR. Vet. Res. 37 219\u2013229.", "ArticleIdList": ["16472521"]}, {"Citation": "Lee S. A., Jung E. B., Lee S. H., Kim Y. J., Bang H., Seo S. J., et al. (2012). 3,4,5-tricaffeoylquinic acid inhibits the lipopolysaccharide-stimulated production of inflammatory mediators in keratinocytes. Pharmacology 90 183\u2013192. 10.1159/000342127", "ArticleIdList": ["10.1159/000342127", "22947851"]}, {"Citation": "Litteljohn D., Mangano E., Clarke M., Bobyn J., Moloney K., Hayley S. (2011). Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson\u2019s disease. Parkinsons Dis. 2011:713517. 10.4061/2011/713517", "ArticleIdList": ["10.4061/2011/713517", "PMC3018622", "21234362"]}, {"Citation": "Liu M., Bing G. (2011). Lipopolysaccharide animal models for Parkinson\u2019s disease. Parkinsons Dis. 2011:327089. 10.4061/2011/327089", "ArticleIdList": ["10.4061/2011/327089", "PMC3096023", "21603177"]}, {"Citation": "Lobo-Silva D., Guilhermina Carriche M., Gil Castro A., Roque S., Saraiva M. (2016). Balancing the immune response in the brain: IL-10 and its regulation. J. Neuroinflammation 13:297. 10.1186/s12974-016-0763-8", "ArticleIdList": ["10.1186/s12974-016-0763-8", "PMC5121946", "27881137"]}, {"Citation": "Maffei-Facino R., Carini M., Aldini G., Saibene L., Morelli R. (1995). Differential inhibition of superoxide, hydroxyl and peroxyl radicals by nimesulide and its main metabolite 4 hydroxy nimesulide. Arzneimittelforschung 45 1102\u20131109.", "ArticleIdList": ["8595069"]}, {"Citation": "Manna S., Bhattacharyya D., Mandal T. K., Dey S. (2006). Neuropharmacological effects of deltamethrin in rats. J. Vet. Sci. 7 133\u2013136. 10.4142/jvs.2006.7.2.133", "ArticleIdList": ["10.4142/jvs.2006.7.2.133", "PMC3242104", "16645337"]}, {"Citation": "McCord J. M., Fridovich I. (1969). The role of superoxide anion in the auto-oxidation of epinephrine and simple assay for superoxide dismutase. J. Biol. Chem. 224 6049\u20136055.", "ArticleIdList": ["5389100"]}, {"Citation": "McCoy M. K., Ruhn K. A., Martinez T. N., McAlpine F. E., Blesch A., Tansey M. G., et al. (2008). Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats. Mol. Ther. 16 1572\u20131579. 10.1038/mt.2008.146", "ArticleIdList": ["10.1038/mt.2008.146", "PMC2670754", "18628756"]}, {"Citation": "Meireles J., Massano J. (2012). Cognitive impairment and dementia in Parkinson\u2019s disease: clinical features, diagnosis, and management. Front. Neurol. 3:88. 10.3389/fneur.2012.00088", "ArticleIdList": ["10.3389/fneur.2012.00088", "PMC3360424", "22654785"]}, {"Citation": "Mogi M., Harada M., Kondo T., Riederer P., Inagaki H., Minami M., et al. (1994). Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from Parkinsonian patients. Neurosci. Lett. 180 147\u2013150. 10.1016/0304-3940(94)90508-8", "ArticleIdList": ["10.1016/0304-3940(94)90508-8", "7700568"]}, {"Citation": "Mohanasundari M., Srinivasan M. S., Sethupathy S., Sabesan M. (2006). Enhanced neuroprotective effect by combination of bromocriptine and hypericum perforatum extract against MPTP-induced neurotoxicity in mice. Neurol. J. Sci. 249 140\u2013144. 10.1016/j.jns.2006.06.018", "ArticleIdList": ["10.1016/j.jns.2006.06.018", "16876826"]}, {"Citation": "Moore K. W., de Waal M. R., Coffman R. L., O\u2019Garra A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 683\u2013765. 10.1146/annurev.immunol.19.1.683", "ArticleIdList": ["10.1146/annurev.immunol.19.1.683", "11244051"]}, {"Citation": "Niranjan R. (2014). The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson\u2019s disease: focus on astrocytes. Mol. Neurobiol. 49 28\u201338. 10.1007/s12035-013-8483-x", "ArticleIdList": ["10.1007/s12035-013-8483-x", "23783559"]}, {"Citation": "Niranjan R., Nath C., Shukla R. (2010). The mechanism of action of MPTP-induced neuroinflammation and its modulation by melatonin in rat astrocytoma cells, C6. Free Radic. Res. 44 1304\u20131316. 10.3109/10715762.2010.501080", "ArticleIdList": ["10.3109/10715762.2010.501080", "20815783"]}, {"Citation": "Ohkawa H., Ohishi N., Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 351\u2013358. 10.1016/0003-2697(79)90738-3", "ArticleIdList": ["10.1016/0003-2697(79)90738-3", "36810"]}, {"Citation": "Obeso J. A. (2010). Modeling clinical features of neurodegeneration. Nat. Med. 16:1372. 10.1038/nm1210-1372b", "ArticleIdList": ["10.1038/nm1210-1372b", "21135843"]}, {"Citation": "Pisa M. (1998). Regional specialization of motor functions in the rat ST: implications for the treatment of Parkinsonism. Prog. Neuropsychopharmacol. Biol. Psychiatry 12 217\u2013224.", "ArticleIdList": ["3290995"]}, {"Citation": "Poewe W. (2008). Non-motor symptoms in Parkinson\u2019s disease. Eur. J. Neurol. 1 14\u201320. 10.1111/j.1468-1331.2008.02056.x", "ArticleIdList": ["10.1111/j.1468-1331.2008.02056.x", "18353132"]}, {"Citation": "Poewe W. S. K., Tanner C. M., Halliday G. M., Halliday G. M., Brundin P., Volkmann J., et al. (2017). Parkinson disease. Nat. Rev. Dis. Primers 23:17013. 10.1038/nrdp.2017.13", "ArticleIdList": ["10.1038/nrdp.2017.13", "28332488"]}, {"Citation": "Przedborski S., Tieu K., Perier C., Vila M. (2004). MPTP as a mitochondrial neurotoxic model of Parkinson\u2019s disease. J. Bioenerg. Biomembr. 36 375\u2013379. 10.1023/B:JOBB.0000041771.66775.d5", "ArticleIdList": ["10.1023/B:JOBB.0000041771.66775.d5", "15377875"]}, {"Citation": "Przedborski S., Vila M. (2003). The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson\u2019s disease. Ann. Acad. N. Y. Sci. 991 189\u2013198.", "ArticleIdList": ["12846987"]}, {"Citation": "Qian L., Block M. L., Wei S. J., Lin C. F., Reece J., Pang H., et al. (2006). Interleukin-10 protects lipopolysaccharide-induced neurotoxicity in primary midbrain cultures by inhibiting them function of NADPH oxidase. J. Pharmacol. Exp. Ther. 319 44\u201352. 10.1124/jpet.106.106351", "ArticleIdList": ["10.1124/jpet.106.106351", "16807359"]}, {"Citation": "Qian Y., Cao L., Guan T., Chen L., Xin H., Li Y., et al. (2015). Protection by genistein on cortical neurons against oxidative stress injury via inhibition of NF-kappaB, JNK and ERK signaling pathway. Pharm. Biol. 53 1124\u20131132. 10.3109/13880209.2014.962057", "ArticleIdList": ["10.3109/13880209.2014.962057", "25715966"]}, {"Citation": "RajaSankar S., Manivasagam T., Sankar V., Prakash S., Muthusamy R., Krishnamurti A., et al. (2009). Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson\u2019s disease model mouse. J. Ethnopharmacol. 125 369\u2013373. 10.1016/j.jep.2009.08.003", "ArticleIdList": ["10.1016/j.jep.2009.08.003", "19666100"]}, {"Citation": "Rappold P. M., Tieu K. (2010). Astrocytes and therapeutics for Parkinson\u2019s disease. Neurotherapeutics 7 413\u2013423. 10.1016/j.nurt.2010.07.001", "ArticleIdList": ["10.1016/j.nurt.2010.07.001", "PMC2948546", "20880505"]}, {"Citation": "Saijo K., Winner B., Carson C. T., Collier J. G., Boyer L., Rosenfeld M. G., et al. (2009). A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137 47\u201359. 10.1016/j.cell.2009.01.038", "ArticleIdList": ["10.1016/j.cell.2009.01.038", "PMC2754279", "19345186"]}, {"Citation": "Samantaray S., Knaryan V. H., Guyton M. K., Matzelle D. D., Ray S. K., Banik N. L. (2007). The Parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motor neurodegeneration in spinal cord of Lewis rats. Neuroscience 146 741\u2013755. 10.1016/j.neuroscience.2007.01.056", "ArticleIdList": ["10.1016/j.neuroscience.2007.01.056", "PMC1940329", "17367952"]}, {"Citation": "Sanchez-Pernaute R. S., Ferree A., Cooper O., Yu M., Liisa Brownell A., Isacson O., et al. (2004). Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson\u2019s disease. J. Neuroinflammation 1:6. 10.1186/1742-2094-1-6", "ArticleIdList": ["10.1186/1742-2094-1-6", "PMC483059", "15285796"]}, {"Citation": "Schapira A. H., Olanow C. W., Greenamyre J. T., Bezard E. (2014). Slowing of neurodegeneration in Parkinson\u2019s disease and Huntington\u2019s disease: future therapeutic perspectives. Lancet 384 545\u2013555. 10.1016/S0140-6736(14)61010-2", "ArticleIdList": ["10.1016/S0140-6736(14)61010-2", "24954676"]}, {"Citation": "Shi H., Dong L., Jiang J., Zhao J., Zhao G., Dang X., et al. (2013). Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology 303 107\u2013114. 10.1016/j.tox.2012.10.025", "ArticleIdList": ["10.1016/j.tox.2012.10.025", "23146752"]}, {"Citation": "Singh S., Singh K., Patel D. K., Singh C., Nath C., Singh V. K., et al. (2009). The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson\u2019s disease phenotype and nicotine mediated neuroprotection. Rejuvenation Res. 12 185\u2013197. 10.1089/rej.2009.0850", "ArticleIdList": ["10.1089/rej.2009.0850", "19594327"]}, {"Citation": "Strle K., Zhou J. H., Shen W. H., Broussard S. R., Johnson R. W., Freund G. G., et al. (2001). Interleukin-10 in the brain. Crit. Rev. Immunol. 21 427\u2013449. 10.1615/CritRevImmunol.v21.i5.20", "ArticleIdList": ["10.1615/CritRevImmunol.v21.i5.20", "11942558"]}, {"Citation": "Sutachan J. J., Casas Z., Albarracin S. L., Stab B. R., II, Samudio I., Gonzalez J., et al. (2012). Cellular and molecular mechanisms of antioxidants in Parkinson\u2019s disease. Nutr. Neurosci. 15 120\u2013126. 10.1179/1476830511Y.0000000033", "ArticleIdList": ["10.1179/1476830511Y.0000000033", "22732354"]}, {"Citation": "Switala J., Loewen P. C. (2002). Diversity of properties among catalases. Arch. Biochem. Biophys. 401 145\u2013154. 10.1016/S0003-9861(02)00049-8", "ArticleIdList": ["10.1016/S0003-9861(02)00049-8", "12054464"]}, {"Citation": "Tanaka T., Kai S., Matsuyama T., Adachi T., Fukuda K., Hirota K. (2013). General anaesthetics inhibit LPS-induced IL-1beta expression in glial cells. PLoS One 8:e82930. 10.1371/journal.pone.0082930", "ArticleIdList": ["10.1371/journal.pone.0082930", "PMC3859610", "24349401"]}, {"Citation": "Tansey M. G., McCoy M. K., Frank-Cannon T. C. (2007). Neuroinflammatory mechanisms in Parkinson\u2019s disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp. Neurol. 208 1\u201325. 10.1016/j.expneurol.2007.07.004", "ArticleIdList": ["10.1016/j.expneurol.2007.07.004", "PMC3707134", "17720159"]}, {"Citation": "Teismann P., Schulz J. B. (2004). Cellular pathology of Parkinson\u2019s disease: astrocytes, microglia and inflammation. Cell Tissue Res. 318 149\u2013161. 10.1007/s00441-004-0944-0", "ArticleIdList": ["10.1007/s00441-004-0944-0", "15338271"]}, {"Citation": "Tiwari N., Kumar V., Gedda M. R., Singh A. K., Singh V. K., Gannavaram S., et al. (2017). Identification and characterization of miRNAs in response to Leishmania donovani infection: delineation of their roles in macrophage dysfunction. Front. Microbiol. 8:314. 10.3389/fmicb.2017.00314", "ArticleIdList": ["10.3389/fmicb.2017.00314", "PMC5332369", "28303124"]}, {"Citation": "Wang W., Liu P., Hao C., Wu L., Wan W., Mao X., et al. (2017). Neoagaro-oligosaccharide monomers inhibit inflammation in LPS-stimulated macrophages through suppression of MAPK and NF-kappaB pathways. Sci. Rep. 7:44252. 10.1038/srep4425", "ArticleIdList": ["10.1038/srep4425", "PMC5339798", "28266652"]}, {"Citation": "Zelko I. N., Mariani T. J., Folz R. J. (2002). Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med. 33 337\u2013349. 10.1016/S0891-5849(02)00905-X", "ArticleIdList": ["10.1016/S0891-5849(02)00905-X", "12126755"]}]}], "History": [{"Year": "2017", "Month": "12", "Day": "2"}, {"Year": "2018", "Month": "6", "Day": "21"}, {"Year": "2018", "Month": "8", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "22", "Hour": "6", "Minute": "1"}, {"Year": "2018", "Month": "8", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["30127737", "PMC6087758", "10.3389/fphar.2018.00757"]}}]}